The world of health care is rapidly evolving with new medicines, technologies, and sources of data emerging every day. The future of health and medicine has never been so promising.
Join us at the Breakthrough Summit, where you'll have the chance to connect with like-minded individuals, share ideas and insights, and gain valuable knowledge about the latest trends and innovations in health and medicine.
GET TICKET
Speaker Spotlight

Amy Abernethy, M.D, Ph.D.
President of Product Development and Chief Medical Officer, Verily
Verily has long been known for its big ambitions to transform health care. CEO Stephen Gillet joins Dr. Abernethy to discuss how the company's now channeling its investments into an effort to transform clinical trials.
Jamy Ard, M.D.
Professor, Wake Forest School of Medicine; Co-Director, Weight Management Center, Atrium Health Wake Forest Baptist
For perhaps the first time ever, new medicines are having a substantial impact on obesity. They promise to improve and maybe even save people's lives. Dr. Ard joins other expert to discuss the risks and potential benefits.

Emily Whitehead
Co-Founder, the Emily Whitehead Foundation
More than a decade ago Emily Whitehead was one of the first people whose cancer was sent into remission by a radical new immunotherapy. Today she's cancer free. Hear about her story and her hopes for the future.
Robert Nelsen
Co-Founder and Managing Director, ARCH Venture Partners
Nelsen has always had a sometimes prophetic, always audacious view of biotech. His latest bets have involved massive raises of capital and potentially crazy ideas about cell therapy, bodily regeneration, and manufacturing. Hear why he goes big – or goes home.
Peter Chin-Hong, M.D.
Associate Dean and Professor, UCSF School of Medicine
Dr. Chin-Hong, and our other panelists, have been go-to sources for trusted information throughout the pandemic. They'll discuss what surprised them most about this public health crisis, how to navigate continuing uncertainty, and what they think lies ahead.
GET TICKET

No comments